Worst Company I Have Ever Worked For - Pathologist NeoGenomics Employee Review

1.0
Feb 6, 2023
Recommend
CEO approval
Business Outlook

Pros

At this point, I'm not sure there are any. I wish I could give half a star.

Cons

This is not the place to serve patients. Upper management does not serve patients, pathologists, or any employees, for that matter. They serve their own Old Boy Network egos and pocketbooks. The bottom line is how fast can you push out cases. No value is placed on any other skill set. If it isn't fast enough, you will receive an unceremonious walk to your car. No advance notice. The stress and burnout from this practice are crumbling this company. Neo took the most inept people from the broken Genoptix and put them in charge. How that is even good business acumen belies logic. Upper management might respond with lip service, but their inaction speaks volumes. Neo can't even figure out basic scheduling. Always scrambling to cover weekends and holidays, because admin deems scheduling beneath them. Neo just laid off over 100 people. There is a reason. This company is positioning itself for sale. I predict that a Quest or a LabCorp will buy them out. This didn't need to happen. It is a direct result of poor management and greed. Neo lost sight of the main objective...serving patients. I'm waiting with bated breath to read Upper Management's standard response to my review. More lip service. Simply run from this place and spare yourself much agony.

Explore other reviews about NeoGenomics

5.0
Mar 11, 2026
Recommend
CEO approval
Business Outlook

Pros

Growing business opportunities for many job seekers

Cons

Ever changing approach on direction on projects

2.0
Mar 2, 2026
Recommend
CEO approval
Business Outlook

Pros

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Cons

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

5
See reviews by: Helpful|Rating|Date|All